Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis

Vincenzo Savica1,2, Domenico Santoro1, Paolo Monardo2, Agostino Mallamace1, Guido Bellinghieri11Experimental and Clinic Department of Internal Medicine and Pharmacology, University of Messina, Italy; 2Nephrology and Dialysis Unit, Papardo Hospital, Messina, ItalyAbstract: Sevelamer carbonate is an a...

Full description

Bibliographic Details
Main Authors:	Vincenzo Savica, Domenico Santoro, Paolo Monardo, Agostino Mallamace, Guido Bellinghieri
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-09-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/sevelamer-carbonate-in-the-treatment-of-hyperphosphatemia-in-patients--a2147

Similar Items

Hyperphosphatemia in chronic kidney disease
by: S. A. Martynov, et al.
Published: (2019-10-01)

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients
by: Shigematsu T, et al.
Published: (2012-05-01)

Socio-economic factors, food habits and phosphorus levels in patients on hemodialysis
by: Domenico Santoro, et al.
Published: (2012-06-01)

Rene e Sport
by: G. Bellinghieri, et al.
Published: (1993-10-01)

Emerging Effects of Sevelamer in Chronic Kidney Disease
by: Ryota Ikee, et al.
Published: (2013-03-01)

Comparison of sevelamer and calcium carbonate in prevention of hypomagnesemia in hemodialysis patients
by: Elahe Jandaghi, et al.
Published: (2021-01-01)

Phosphate binders in chronic kidney disease: The positions of sevelamer
by: V V Fomin, et al.
Published: (2013-06-01)

Vitamin D Receptor Gene Polymorphism and Left Ventricular Hypertrophy in Chronic Kidney Disease
by: Domenico Santoro, et al.
Published: (2014-03-01)

Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients
by: Eufrônio José d'Almeida Filho, et al.
Published: (2000-11-01)

Use of sevelamer in chronic kidney disease: beyond phosphorus control
by: Laura Rodríguez-Osorio, et al.
Published: (2015-03-01)

Effect of Sevelamer on Mineral and Lipid Abnormalities in Hemodialysis Patients
by: Hamida Fethi, et al.
Published: (2008-01-01)

Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.
by: Yong Wang, et al.
Published: (2015-01-01)

Sevelamer versus calcium-based phosphate binders for chronic kidney disease
by: Gonzalo A Bravo-Soto
Published: (2017-06-01)

The Effect of Magnesium Oxide on Hyperphosphatemia in Female Hemodialysis Patients
by: Maryam Pakfetrat, et al.
Published: (2014-07-01)

Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
by: Yu-Feng Lin, et al.
Published: (2010-09-01)

Effects of phosphate binding with sevelamer carbonate on cardiovascular structure and function in patients with early chronic kidney disease
by: Chue, Colin Dominic
Published: (2013)

A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis
by: Moustafa M, et al.
Published: (2014-04-01)

Intensified treatment of hyperphosphatemia associated with reduction in parathyroid hormone in patients on maintenance hemodialysis
by: Lan Chen, et al.
Published: (2018-10-01)

Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action
by: Bahaa Eldin Zayed, et al.
Published: (2015-01-01)

Sevelamer Carbonate Crystal-Induced Colitis
by: T. Lai, et al.
Published: (2020-01-01)

Preparation and Characterization of Lanthanum Carbonate Octahydrate for the Treatment of Hyperphosphatemia
by: Anqi He, et al.
Published: (2013-01-01)

Hyperphosphatemia: The risk factor for adverse outcome in maintenance hemodialysis patients
by: Petrović Dejan, et al.
Published: (2012-01-01)

The importance of nutritional intervention by dietitians for hyperphosphatemia in maintained hemodialysis patients
by: Yuka Kawate, et al.
Published: (2017-04-01)

Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients
by: Farrokhlagha Ahmadi, et al.
Published: (2012-01-01)

Adesão e conhecimento sobre o tratamento da hiperfosfatemia de pacientes hiperfosfatêmicos em hemodiálise Adherence and knowledge about hyperphosphatemia treatment in hemodialysis patients with hyperphosphatemia
by: Fabiana B. Nerbass, et al.
Published: (2010-06-01)

Practical use of sevelamer in chronic kidney disease patients on dialysis in People’s Republic of China
by: Meng L, et al.
Published: (2015-04-01)

Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure
by: Olivier Phan, et al.
Published: (2015-01-01)

Hyperphosphatemia is not significantly associated with increased all-cause mortality in Korean hemodialysis patients
by: Minako Wakasugi, et al.
Published: (2018-12-01)

Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
by: Ju-Young Moon, et al.
Published: (2015-03-01)

Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial
by: Edward R. Smith, et al.
Published: (2020-09-01)

Hyperphosphatemia is a complication of reduced kidney functions and limit for renoprotection
by: S.V. Kushnirenko
Published: (2020-02-01)

Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury
by: Phuong Chi Pham, et al.
Published: (2021-01-01)

Prevalence of hyperphosphatemia and phosphorus intake in patients with chronic renal disease undergoing hemodialysis in a medium-sized Brazilian municipality
by: Joice Natielle Mariano de Almeida, et al.
Published: (2020-08-01)

Effects of developing an m-health App to improve the diet control for hyperphosphatemia of hemodialysis patients
by: YANG, CHIEH, et al.
Published: (2019)

Efficacy and safety of calcium acetate-magnesium carbonate in the treatment of hyperphosphatemia in dialysis patients
by: Imed Helal, et al.
Published: (2016-01-01)

Elemental calcium intake associated with calcium acetate/calcium carbonate in the treatment of hyperphosphatemia
by: Rosamund J Wilson, et al.
Published: (2017-01-01)

Hyperphosphatemia and Cardiovascular Disease
by: Chao Zhou, et al.
Published: (2021-03-01)

Intensive Dietary Education Using the Phosphorus Point System Tool© to Improve Hyperphosphatemia in Patients with Chronic Kidney Disease
by: Degen, Amanda
Published: (2009)

Intensive Dietary Education Using the Phosphorus Point System Tool© to Improve Hyperphosphatemia in Patients with Chronic Kidney Disease
by: Degen, Amanda
Published: (2009)

Perdite Ematiche Nel Circuito Extracorporeo
by: G. Bellinghieri, et al.
Published: (1991-07-01)